Tunable dual growth factor delivery from polyelectrolyte multilayer films

Biomaterials

Volumn 32, Issue 26, 2011, Pages 6183-6193

  Shah, Nisarg J ^a,b   Macdonald, Mara L ^a,b   Beben, Yvette M ^b   Padera, Robert F ^b,c   Samuel, Raymond E ^a   Hammond, Paula T ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

BMP; Bone; Controlled drug release; Layer by layer; VEGF

Indexed keywords

AMINO ESTERS; BMP; BURST RELEASE; CONTROLLED DRUG RELEASE; DOSE-DEPENDENT; DOSE-DEPENDENT MANNER; ECTOPIC BONES; FAILURE RATE; GROWTH FACTOR; GROWTH FACTOR DELIVERY; HEALING PROCESS; HUMAN BONE MORPHOGENETIC PROTEIN; IN-VITRO ASSAYS; IN-VIVO; JOINT IMPLANTS; LAYER-BY-LAYER TECHNIQUES; LAYER-BY-LAYERS; MINERAL DENSITY; OSTEOGENIC; OSTEOPOROTIC FRACTURES; POLYELECTROLYTE MULTILAYER FILM; RECOMBINANT HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOVERY TIME; RELEASE PROFILES; RHBMP-2; TRABECULAR THICKNESS; VASCULAR NETWORK; VEGF;

ANIMAL CELL CULTURE; BONE; MULTILAYERS; PEPTIDES; POLYELECTROLYTES;

MULTILAYER FILMS;

POLYELECTROLYTE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITOMETRY; BONE REMODELING; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FILM; FRAGILITY FRACTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; POLYELECTROLYTE MULTILAYER FILM; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; THICKNESS; TRABECULAR BONE; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; MICE; POLYMERS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959900850     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.04.036     Document Type: Article

References (50)

1. Ince A., Rupp J., Frommelt L., Katzer A., Gille J., Lohr J.F. Is "aseptic" loosening of the prosthetic cup after total hip replacement due to nonculturable bacterial pathogens in patients with low-grade infection?. Clin Infect Dis 2004, 39(11):1599-1603.
2. Harris W.H., Sledge C.B. Total hip and total knee replacement. N Engl J Med 1990, 323(11):725-731.
3. Street J., Bao M., deGuzman L., Bunting S., Peale F.V., Ferrara N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002, 99(15):9656-9661.
4. Lieberman J.R., Daluiski A., Einhorn T.A. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Jt Surg Am 2002, 84-A(6):1032-1044.
5. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242(4885):1528-1534.
6. Patel Z.S., Young S., Tabata Y., Jansen J.A., Wong M.E., Mikos A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008, 43(5):931-940.
7. Kempen D.H., Lu L., Heijink A., Hefferan T.E., Creemers L.B., Maran A., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009, 30(14):2816-2825.
8. Sellers R.S., Peluso D., Morris E.A. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Jt Surg Am 1997, 79(10):1452-1463.
9. Gerhart T.N., Kirker-Head C.A., Kriz M.J., Holtrop M.E., Hennig G.E., Hipp J., et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop Relat Res 1993, 293:317-326.
10. Uludag H., Gao T.J., Porter T.J., Friess W., Wozney J.M. Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Jt Surg Am 2001, 83A:S128-S135.
11. Jennissen H.P. Accelerated and improved osteointegration of implants biocoated with bone morphogenetic protein 2 (BMP-2). Ann N Y Acad Sci 2002, 961:139-142.
12. Maus U., Andereya S., Gravius S., Ohnsorge J.A., Niedhart C., Siebert C.H. BMP-2 incorporated in a tricalcium phosphate bone substitute enhances bone remodeling in sheep. J Biomater Appl 2008, 22(6):559-576.
13. Peng H., Usas A., Olshanski A., Ho A.M., Gearhart B., Cooper G.M., et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 2005, 20(11):2017-2027.
14. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5(6):623-628.
15. Samee M., Kasugai S., Kondo H., Ohya K., Shimokawa H., Kuroda S. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci 2008, 108(1):18-31.
16. Murphy W.L., Peters M.C., Kohn D.H., Mooney D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 2000, 21(24):2521-2527.
17. Luginbuehl V., Meinel L., Merkle H.P., Gander B. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 2004, 58(2):197-208.
18. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19(11):1029-1034.
19. Nielsen H.M., Andreassen T.T., Ledet T., Oxlund H. Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop Scand 1994, 65(1):37-41.
20. Lutolf M.P., Weber F.E., Schmoekel H.G., Schense J.C., Kohler T., Muller R., et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003, 21(5):513-518.
21. Saito N., Okada T., Horiuchi H., Ota H., Takahashi J., Murakami N., et al. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. Bone 2003, 32(4):381-386.
22. Simmons C.A., Alsberg E., Hsiong S., Kim W.J., Mooney D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004, 35(2):562-569.
23. Zara J., Siu R.K., Zhang X., Shen J., Ngo R., Lee M., et al. High doses of BMP2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 2011, 17(9-10).
24. Fu K., Pack D.W., Klibanov A.M., Langer R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res 2000, 17(1):100-106.
25. Jeon O., Song S.J., Yang H.S., Bhang S.H., Kang S.W., Sung M.A., et al. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun 2008, 369(2):774-780.
26. Kokubu T., Hak D.J., Hazelwood S.J., Reddi A.H. Development of an atrophic nonunion model and comparison to a closed healing fracture in rat femur. J Orthop Res 2003, 21(3):503-510.
27. Eckardt H., Bundgaard K.G., Christensen K.S., Lind M., Hansen E.S., Hvid I. Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis. J Orthop Res 2003, 21(2):335-340.
28. Zisch A.H., Lutolf M.P., Hubbell J.A. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 2003, 12(6):295-310.
29. Zhang S., Uludag H. Nanoparticulate systems for growth factor delivery. Pharm Res 2009, 26(7):1561-1580.
30. Decher G. Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 1997, 277:1232.
31. Moskowitz J.S., Blaisse M.R., Samuel R.E., Hsu H.-P., Harris M.B., Martin S.D., et al. The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of staphylococcus aureus infection in a rabbit bone model. Biomaterials 2010, 31:6019-6030.
32. Kim B.S., Smith R.C., Poon Z., Hammond P.T. MAD (multiagent delivery) nanolayer: delivering multiple therapeutics from hierarchically assembled surface coatings. Langmuir 2009, 25(24):14086-14092.
33. Shukla A., Fleming K.E., Chuang H.F., Chau T.M., Loose C.R., Stephanopoulos G.N., et al. Controlling the release of peptide antimicrobial agents from surfaces. Biomaterials 2010, 31(8):2348-2357.
34. Macdonald M.L., Rodriguez N.M., Shah N.J., Hammond P.T. Characterization of tunable FGF-2 releasing polyelectrolyte multilayers. Biomacromolecules 2010, 11(8):2053-2059.
35. Macdonald M.L., Samuel R.E., Shah N.J., Padera R.F., Beben Y.M., Hammond P.T. Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. Biomaterials 2011, 32(5):1446-1453.
36. Zelikin A.N. Drug releasing polymer thin films: new era of surface-mediated drug delivery. ACS Nano 2010, 4(5):2494-2509.
37. Facca S., Cortez C., Mendoza-Palomares C., Messadeq N., Dierich A., Johnston A.P.R., et al. Active multilayered capsules for in vivo bone formation. Proc Natl Acad Sci U S A 2010, 107(8):3406-3411.
38. Dierich A., Le Guen E., Messaddeq N., Stoltz J.F., Netter P., Schaaf P., et al. Bone formation mediated by synergy-acting growth factors embedded in a polyelectrolyte multilayer film. Adv Mat 2007 Mar, 19(5):693-697.
39. Pavlukhina S., Lu Y., Patimetha A., Libera M., Sukhishvili S. Polymer multilayers with pH-triggered release of antibacterial agents. Biomacromolecules 2010, 11(12):3448-3456.
40. Ai H., Jones S.A., Lvov Y.M. Biomedical applications of electrostatic layer-by-layer nano-assembly of polymers, enzymes, and nanoparticles. Cell Biochem Biophys 2003, 39(1):23-43.
41. Kotov N.A., Tang Z.Y., Wang Y., Podsiadlo P. Biomedical applications of layer-by-layer assembly: from biomimetics to tissue engineering. Adv Mat 2006, 18(24):3203-3224.
42. Lynn D.M., Langer R. Degradable poly(beta-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc 2000, 122:10761-10768.
43. Gregory C.A., Gunn W.G., Peister A., Prockop D.J. An alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004, 329(1):77-84.
44. Zhang J., Chua L.S., Lynn D.M. Multilayered thin films that sustain the release of functional DNA under physiological conditions. Langmuir 2004, 20(19):8015-8021.
45. Wood K.C., Chuang H.F., Batten R.D., Lynn D.M., Hammond P.T. Controlling interlayer diffusion to achieve sustained, multiagent delivery from layer-by-layer thin films. Proc Natl Acad Sci U S A 2006, 103(27):10207-10212.
46. Kirker K.R., Luo Y., Nielson J.H., Shelby J., Prestwich G.D. Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials 2002, 23(17):3661-3671.
47. Macdonald M., Rodriguez N.M., Smith R., Hammond P.T. Release of a model protein from biodegradable self assembled films for surface delivery applications. J Control Release 2008, 131:228-234.
48. Shukla A., Avadhany S.N., Fang J.C., Hammond P.T. Tunable vancomycin releasing surfaces for biomedical applications. Small 2010, 6(21):2392-2404.
49. Zacharia N.S., Modestino M., Hammond P.T. Factors influencing the interdiffusion of weak polycations in multilayers. Macromolecules 2007, 40(26):9523-9528.
50. Myoken Y., Kayada Y., Okamoto T., Kan M., Sato G.H., Sato J.D. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci U S A 1991, 88(13):5819-5823.